Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia

Drug and Alcohol Review

Volumn 28, Issue 6, 2009, Pages 592-599

  Wallace, Cate ^a   Galloway, Tony ^b   McKetin, Rebecca ^c   Kelly, Erin ^c   Leary, John ^b  

^a New South Wales Government   (Australia)

^b North Coast Area Health Service   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dependence; Methamphetamine; Rural and regional; Treatment access

Indexed keywords

METHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; COMPARATIVE STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH; HEALTH CARE DELIVERY; HUMAN; MALE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RURAL HEALTH CARE; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; CHILD; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; METHAMPHETAMINE; NEW SOUTH WALES; QUESTIONNAIRES; RURAL HEALTH; RURAL HEALTH SERVICES; SUBSTANCE ABUSE TREATMENT CENTERS; YOUNG ADULT;

EID: 76949088164     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2008.00016.x     Document Type: Article

References (44)

1. Hall W, Darke S, Ross M, Wodak A. Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia. Addiction 1993;88:509-16.
2. Gourlay DL. Amphetamines. In: Brands B, ed. Management of alcohol, tobacco and other drug problems, pages. Toronto, Canada: Centre for Addiction and Mental Health, 2000:79-94.
3. Latt N, White J, McLean S, Young R, Saunders J. Central nervous system stimulants. In Hulse G, White J, Cape G, eds. Management of alcohol and drug problems. South Melbourne, Vic.: Oxford University Press, 2002:124-40.
4. Saunders J, Young R. Medical and psychological problems. In: Hulse G, White J, Cape G, eds. Management of alcohol and drug problems. South Melbourne,Vic.: Oxford University Press, 2002:32-44.
5. Buchacz K, McFarland W, Kellogg TA, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19:1423-4.
6. Burcham JL, Tindall B, Marmor M, Cooper DA, Berry G, Penny R. Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust 1989;150:634-39.
7. Degenhardt L, Topp L. Crystal meth' use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harms. Int J Drug Policy 2003;14:17-24.
8. Hando J, Topp L, Hall W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug Alcohol Depend 1997;46:105-13.
9. Davis JM, Schlemmer RF. The amphetamine psychosis. In: Caldwell J, ed. Amphetamine and related stimulants: chemical, biological, clinical and sociological aspects. Boca Raton, FL: CRC Press, 1980:161-73.
10. Australian Institute of Health and Welfare. Statistics on drug use in Australia 2004. Canberra: AIHW, 2005. Drug Statistics Series No. 15, AIHW Catalogue No: PHE 62.
11. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101:1473-8.
12. Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 2007;186:336-9.
13. McKetin R, McLaren J, Riddell S, Robins L. The relationship between methamphetamine use and violent behaviour. Crime Justice Bull 2006;1-15. NSW Bureau of Crime Statistics and Research. Available at: http://www.lawlink.nsw.gov.au/lawlink/bocsar/II_bocsar.nsf/pages/bocsar_ pub_cjb.
14. Topp L, Degenhardt L, Kaye S, Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. Drug Alcohol Rev, 2002;4:341-8.
15. Lee N, Johns L, Jenkinson R, et al. Clinical treatment guidelines for alcohol and drug clinicians. No 14: methamphetamine dependence and treatment. Fitzroy, Vic.: Turning Point Alcohol and Drug Centre Inc., 2007.
16. Vincent N, Shoobridge J, Ask A, Allsop S, Ali R. Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug Alcohol Rev 1998; 17:187-95.
17. Baker A, Lee NK, Claire M, et al. Drug use patterns and mental health of regular amphetamine users during a reported 'heroin drought'. Addiction 2004;99:875-84.
18. McKetin R, Kelly E, Indig D. Characteristics of treatment provided for amphetamine use in New South Wales, Australia. Drug Alcohol Rev 2005;24:433-6.
19. Day C, Conroy E, Lowe J, Dolan K. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users. Aust J Rural Health 2006;14:120-5.
20. Aitken C, Brough R, Crofts N. Injecting drug use and blood-borne viruses: a comparison of rural and urban Victoria, 1990-95. Drug Alcohol Rev 1999;8:47-52.
21. Lynch M, Kemp R, Krenske L, Conroy A, Webster J. Patterns of amphetamine use. Initial findings from the amphetamines in Queensland research project 2003. Brisbane: Crime and Misconduct Commission, 2003.
22. Grant KM, Kelley SS, Agrawal S, Meza JL, Meyer JR, Romberger DJ. Methamphetamine use in rural Midwesterners. AM J Addiction 2007;16:79-84.
23. Stoops WW, Tindall MS, Mateyoke-Scrivner A, Leukefeld C. Methamphetamine use in nonurban and urban drug court clients. Int J Offender Ther Comp Criminol 2005; 49;260-76.
24. Wang J, Carlson RG, Falck RS, Leukefeld C, Booth BM. Multi-sample standardization and decomposition analysis: an application to comparisons of methamphetamine use among rural drug users in three American states. Stat Med 2007;26:3612-23.
25. Department of Transport and Regional Services. A regional profile: northern rivers and North Coast region of New South Wales. Canberra: Commonwealth of Australia, 2005.
26. NSW Health Department. New South Wales population health survey: 2006 report on adult health. North Sydney: Centre for Epidemiology and Research, NSW Health Department, 2007.
27. Ware JE, Kosinski M, Bayliss M, McHorney C, Rogers W, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 1995;33:AS264-79.
28. Sanderson K, Andrews G. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv 2002;53:80-6.
29. Darke S,Ward J, Hall W, Heather N,Wodak A. The Opiate Treatment Index (OTI) manual. National Drug and Alcohol Research Centre Technical Report No. 11. Sydney: National Drug and Alcohol Centre, 1991.
30. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607-14.
31. Topp L, Mattick R. Choosing a cut-off on the SDS for amphetamine users. Addiction 1997;92:839-45.
32. SPSS Inc. SPSS 13.0 brief guide. Chicago, IL: SPSS Inc., 2004.
33. The Royal Australian College of General Practitioners, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Pharmaceutical Society of Australia. Australian Medicines Handbook, 2006. Adelaide: Australian Medicines Handbook Pty Ltd, 2006.
34. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005;352:1112-20.
35. McKetin R, Kelly E. Socio-demographic predictors of methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug Alcohol Rev 2007;25:161-8.
36. Lawrinson P, Copeland J, Indig D. Regional differences in injecting practices and other substance use-related behaviour among entrants into opioid maintenance pharmacotherapy treatment in New South Wales, Australia. Drug Alcohol Depend 2006;82 (Suppl. 1):S95-102.
37. Strain EC, Brooner RK, Bigelow GE. Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. Drug Alcohol Depend 1991;27:127-34.
38. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998;51:253-63.
39. Baker A, Lee NK. A review of psychosocial interventions for amphetamine use. Drug Alcohol Rev 2003;22:323-35.
40. Baker A, Lee NK, Claire M, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction 2005;100:367-78.
41. Shoptaw S, Klausner JD, Reback CJ, et al. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 2006;6:214.
42. Baker A, Lee NK, Jenner L (eds.) Models of intervention and care for psychostimulant users, 2nd edn. National Drug Strategy Monograph series no. 51. Canberra: Commonwealth of Australia, 2004.
43. Shoptaw S, Reback CJ, Peck JA, et al. Behavioral treatment approaches for methamphetamine dependence and HIVrelated sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005;78:125-34.
44. Bradley AC, Baker A, Lewin TJ. Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years. Aust NZ J Psychiatry 2007;41:501-8.